source
- White House science blueprint pushes billions toward AI firms, away from university life-science researchThe White House Office of Science and Technology Policy released a report titled “Science: A New Golden Age.” The document outlines a new direction for U.S. federal science funding. The plan calls…
- Sanofi drops pursuit of eczema drug amlitelimab after failed Phase 3 trialsSanofi announced it will no longer seek regulatory approval for amlitelimab, an anti‑OX40 ligand antibody intended for atopic dermatitis, after recent Phase 3 data fell short of expectations. The…